腐生菌疗法:从基础生物学到临床应用的作者修正
Author Correction: Phage therapy: from basic biology to clinical application
Nature Reviews Microbiology 发表了对一篇关于腐生菌疗法的文章的作者修正,修正内容包括图像分类调整、文字错误更正及参考文献补充。
- Author Correction
- Published: 26 October 2026
- Holly A. Sinclair ORCID: orcid.org/0009-0008-3341-69221,2,3,4,
- Ruby C. Y. Lin ORCID: orcid.org/0000-0003-4163-511X1,3,4,
- Nouri L. Ben Zakour ORCID: orcid.org/0000-0002-6949-17551,3,4,
- Paul L. Bollyky5 &
- …
- Jonathan R. Iredell ORCID: orcid.org/0000-0003-2469-70601,2,3,4
Nature Reviews Microbiology (2026) Cite this article
Correction to: Nature Reviews Microbiology https://doi.org/10.1038/s41579-026-01352-5, published online 27 August 2026.
In the version of the article initially published, in Box 1, the second image of a bacteriophage in the “Myovirus” row is a podovirus morphotype and so has been moved to the “Podovirus” row. Additionally, the credit line “Images courtesy of Laela Bouaou and Alicia Fajardo Lubian” was originally missing. In Fig. 1, a question mark has been added to one of the arrows in the “Pseudolysogenic L-form” section. The second to last sentence of the Fig. 1 legend ended with “…if stringent conditions persist (exclamation mark), for which an episomal phase is not defined (question mark)” instead of “…if stringent conditions persist (exclamation mark). Episomal phases have not been defined in stressed or L-form growth conditions (question mark).” In the penultimate paragraph of the “Phage life cycles in nature and in human infection” section, two references are now cited in the sentence ending “…possibly also with phages in episomal forms”: Kawakami, M. & Landman, O. E. Retention of episomes during protoplasting and during propagation in the L state. J. Bacteriol. 92, 398–404 (1966) and Mohammadi, T. & Ely, B. Dolichocephalovirinae phages exist as episomal pseudolysogens across diverse soil bacteria. Microorganisms 13, 1239 (2025). These corrections have been made to the HTML and PDF versions of the article.
Author information
Authors and Affiliations
Centre for Infectious Diseases and Microbiology, Westmead Institute for Medical Research, Sydney, New South Wales, Australia
Holly A. Sinclair, Ruby C. Y. Lin, Nouri L. Ben Zakour & Jonathan R. Iredell
Department of Infectious Diseases, Westmead Hospital, Western Sydney Local Health District, Sydney, New South Wales, Australia
Holly A. Sinclair & Jonathan R. Iredell
Sydney ID/Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia
Holly A. Sinclair, Ruby C. Y. Lin, Nouri L. Ben Zakour & Jonathan R. Iredell
Phage Australia, Western Sydney Local Health District, Sydney, New South Wales, Australia
Holly A. Sinclair, Ruby C. Y. Lin, Nouri L. Ben Zakour & Jonathan R. Iredell
Division of Infectious Diseases and Geographic Medicine, Department of Medicine, Stanford University, Stanford, CA, USA
Paul L. Bollyky
Authors
- Holly A. Sinclair
- Ruby C. Y. Lin
- Nouri L. Ben Zakour
- Paul L. Bollyky
- Jonathan R. Iredell
Corresponding author
Correspondence to Jonathan R. Iredell.
About this article
Cite this article
Sinclair, H.A., Lin, R.C.Y., Ben Zakour, N.L. et al. Author Correction: Phage therapy: from basic biology to clinical application. Nat Rev Microbiol (2026). https://doi.org/10.1038/s41579-026-01394-9
Published: 26 October 2026
Version of record: 26 October 2026
DOI: https://doi.org/10.1038/s41579-026-01394-9
来源:Nature Reviews Microbiology · nature.com